Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

Heartflow has pumped up its IPO ambitions, raising its proposal into the vicinity of $300 million. | After first pricing its ...

Heartflow on Wednesday said it now plans to sell nearly 16.7 million shares at between $17 and $18 apiece in the IPO, compared with prior plans to offer 12.5 million shares at between $15 and $17 each ...